MELISSA THIERRY: Open Payments
NPI 1841541158 · PASCAGOULA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 72 payments from 15 companies in 2025. Trend: 2023 $1,453 · 2024 $905 · 2025 $1,317
Food & beverage: $1,317
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $254 |
| Organon LLC | 5 | $166 |
| Galderma Laboratories, L.P. | 8 | $161 |
| Janssen Biotech, Inc. | 16 | $156 |
| LEO Pharma Inc. | 5 | $149 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| GENZYME CORPORATION | 4 | $77 |
| Incyte Corporation | 3 | $72 |
| Amgen Inc. | 2 | $44 |
| REVANCE THERAPEUTICS, INC. | 1 | $39 |
Products named: SKYRIZI, TREMFYA, ANZUPGO, NEMLUVIO, DUPIXENT, OPZELURA, ADBRY, VTAMA.
Industry payments across MS — which companies pay providers there.
